Literature DB >> 15713121

High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2).

Sabrina Battista1, Monica Fedele, Josefina Martinez Hoyos, Francesca Pentimalli, Giovanna Maria Pierantoni, Rosa Visone, Ivana De Martino, Carlo Maria Croce, Alfredo Fusco.   

Abstract

HMGA1 (high-mobility-group A1) proteins are architectural transcription factors that are found overexpressed in embryogenesis and malignant tumours. We have shown previously that they have a role in lymphopoiesis, since the loss of HMGA1 expression leads to an impairment of T-cell development and to an increase in B-cell population. Since RAGs (recombination activating genes) are key regulators of lymphoid differentiation, in the present study we investigate whether RAG2 expression is dependent on HMGA1 activity. We show that RAG2 gene expression is up-regulated in Hmga1-/- ES (embryonic stem) cells and EBs (embryoid bodies) as well as in yolk sacs and fibroblasts from Hmga1-/- mice, suggesting that HMGA1 proteins control RAG2 gene expression both in vitro and in vivo. We show that the effect of HMGA1 on RAG2 expression is direct, identify the responsible region in the RAG2 promoter and demonstrate binding to the promoter in vivo using chromatin immunoprecipitation. Since RAG2 is necessary for lymphoid cell development, our results suggest a novel mechanism by which HMGA1 might regulate lymphoid differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713121      PMCID: PMC1184541          DOI: 10.1042/BJ20041607

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

Review 1.  The RAG proteins and V(D)J recombination: complexes, ends, and transposition.

Authors:  S D Fugmann; A I Lee; P E Shockett; I J Villey; D G Schatz
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Directional binding of HMG-I(Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1.

Authors:  D A Hill; M L Pedulla; R Reeves
Journal:  Nucleic Acids Res       Date:  1999-05-15       Impact factor: 16.971

3.  DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations.

Authors:  K Hiom; M Melek; M Gellert
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

4.  HMGA1 protein expression sensitizes cells to cisplatin-induced cell death.

Authors:  Gustavo Baldassarre; Barbara Belletti; Sabrina Battista; Milena S Nicoloso; Francesca Pentimalli; Monica Fedele; Carlo M Croce; Alfredo Fusco
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

5.  Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins.

Authors:  S John; R B Reeves; J X Lin; R Child; J M Leiden; C B Thompson; W J Leonard
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

6.  Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines.

Authors:  J Lauring; M S Schlissel
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

7.  Lineage-specific regulation of the murine RAG-2 promoter: GATA-3 in T cells and Pax-5 in B cells.

Authors:  H Kishi; X C Wei; Z X Jin; Y Fujishiro; T Nagata; T Matsuda; A Muraguchi
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

8.  Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders.

Authors:  T Wada; K Takei; M Kudo; S Shimura; Y Kasahara; S Koizumi; K Kawa-Ha; Y Ishida; S Imashuku; H Seki; A Yachie
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

9.  The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis.

Authors:  S Battista; V Fidanza; M Fedele; A J Klein-Szanto; E Outwater; H Brunner; M Santoro; C M Croce; A Fusco
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

10.  Partial V(D)J recombination activity leads to Omenn syndrome.

Authors:  A Villa; S Santagata; F Bozzi; S Giliani; A Frattini; L Imberti; L B Gatta; H D Ochs; K Schwarz; L D Notarangelo; P Vezzoni; E Spanopoulou
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

View more
  4 in total

1.  HMGA1 negatively regulates NUMB expression at transcriptional and post transcriptional level in glioblastoma stem cells.

Authors:  Francesca Puca; Nadia Tosti; Antonella Federico; Yalçın Kuzay; Anna Pepe; Sonia Morlando; Teresa Savarese; Federica D'Alessio; Marianna Colamaio; Daniela Sarnataro; Sihana Ziberi; Marco De Martino; Alfredo Fusco; Sabrina Battista
Journal:  Cell Cycle       Date:  2019-05-22       Impact factor: 4.534

Review 2.  Interplay between HMGA and TP53 in cell cycle control along tumor progression.

Authors:  Nathalia Meireles Da Costa; Antonio Palumbo; Marco De Martino; Alfredo Fusco; Luis Felipe Ribeiro Pinto; Luiz Eurico Nasciutti
Journal:  Cell Mol Life Sci       Date:  2020-09-12       Impact factor: 9.261

Review 3.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

4.  Identification of genes differentially expressed in benign versus malignant thyroid tumors.

Authors:  Nijaguna B Prasad; Helina Somervell; Ralph P Tufano; Alan P B Dackiw; Michael R Marohn; Joseph A Califano; Yongchun Wang; William H Westra; Douglas P Clark; Christopher B Umbricht; Steven K Libutti; Martha A Zeiger
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.